US: 800.298.5699
Int'l: +1.240.747.3093
 
Matching geography
Reports matching your search in:
 
 
Join Alert Me now!
Receive bi-weekly email alerts on new market research

Sign up today!
 

Gastrointestinal Market Research Reports & Industry Analysis

RSS Feeds

Gastrointestinal Industry Research & Market Reports

6  7  8  9    11    13  14  15  
Duodenal Ulcer-API Insights, 2015
4/21/2015 | published by: DelveInsight
... the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Duodenal Ulcer. The Report provides the India and China API Manufactures who are driving the ...  |  read more...
USD 1,250
Reflux Esophagitis (Gastroesophageal Reflux Disease)-API Insights, 2015
4/21/2015 | published by: DelveInsight
... the location. The report gives the clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Reflux Esophagitis (Gastroesophageal Reflux Disease). The ...  |  read more...
USD 1,250
Gastric Motility Disorder-API Insights, 2015
4/21/2015 | published by: DelveInsight
... clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Gastric Motility Disorder. The Report provides the India and China API Manufactures ...  |  read more...
USD 1,250
Helicobacter Pylori Infections-API Insights, 2015
4/21/2015 | published by: DelveInsight
... clear idea on the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Helicobacter Pylori Infections. The Report provides the India and China API Manufactures ...  |  read more...
USD 1,250
Intestinal Tumors-API Insights, 2015
4/21/2015 | published by: DelveInsight
... the United States Drug Master File (USDMF) and Europe DMF filed by worldwide countries related to the drugs falling under Intestinal Tumors. The Report provides the India and China API Manufactures who are driving the ...  |  read more...
USD 1,250
Gastrointestinal Remedies - US - July 2014
7/1/2014 | published by: Mintel International Group Ltd.
... must look to brand extension within the natural realm, improve consumer education, and leverage OTC remedies as a way to combat and prevent GI issues among an increasingly stressed out society." – Molly Maier, Category ...  |  read more...
USD 3,995
EpiCast Report: Irritable Bowel Syndrome - Epidemiology Forecast to 2023
10/27/2014 | published by: GlobalData
... habit. Due to the lack of a demonstrable structural abnormality to explain these symptoms, IBS is classified as a functional gastrointestinal disorder. IBS is one of the most common gastrointestinal disorders; moreover, it has a ...  |  read more...
USD 3,995
Irritable Bowel Syndrome- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Nausea -API Insights, 2014
11/21/2014 | published by: DelveInsight
... drugs going off patent in the coming years. It is going to affect the revenue of the API market as generic drugs occupy the market. India and China produce a large percentage of a majority ...  |  read more...
USD 1,250
Acid Indigestion / Heartburn/ Pyrosis- Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... 2014”, report provides comprehensive insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III ...  |  read more...
USD 2,000
Helicobacter Pylori Infections Market Analysis, Global API Manufacturers and Phase III Pipeline Assessment, 2014
11/21/2014 | published by: DelveInsight
... insights about phase III pipeline drugs and marketed drugs across the indication. A key objective of the report is to establish the understanding for API Manufacturers for marketed and Phase III pipeline drugs across the ...  |  read more...
USD 2,000
Peptic Ulcers - Pipeline Review, H2 2014
9/15/2014 | published by: Global Markets Direct
... therapeutic development for Peptic Ulcers, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type, along with latest updates, and featured news ...  |  read more...
USD 2,000
Gut and Digestive Health Ingredients & Consumer Products - Market Trends and Insights
10/31/2014 | published by: Canadean Ltd
... provide effective products that can help manage illness and intolerances, as well as promote overall health. Global demand for probiotics is predicted to grow at a CAGR of 6.8% from 2013 to 2018. The gastrointestinal ...  |  read more...
USD 3,495
Global Gastrointestinal OTC Drugs Market 2015-2019
4/15/2015 | published by: TechNavio - Infiniti Research Ltd.
... regulatory agencies to ensure their safety and efficacy. Gastrointestinal OTC drugs can be bought off-the-shelf. Gastrointestinal OTC drugs are used for indications such as GERD, vomiting, constipation, diarrhea, and flatulence. Some of the OTC drugs ...  |  read more...
USD 2,500
Global Inflammatory Bowel Disease Market 2015-2019
4/15/2015 | published by: TechNavio - Infiniti Research Ltd.
... GI tract. Both Crohn's disease and ulcerative colitis include symptoms such as severe persistent diarrhea, abdominal cramps and pain, rectal bleeding, fatigue, and weight loss. Inflammatory bowel disease can also prove to be life-threatening for ...  |  read more...
USD 3,000
Irritable Bowel Syndrome Partnering 2009-2014
11/1/2014 | published by: Current Partnering
... in irritable bowel syndrome partnering deals Top irritable bowel syndrome deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Irritable Bowel Syndrome Partnering 2009-2014 provides understanding and access ...  |  read more...
USD 1,495
Gastrointestinal Symptoms Partnering 2010-2015
3/1/2015 | published by: Current Partnering
... partnering deals Top gastrointestinal symptoms deals by value Deals listed by company A-Z, industry sector, stage of development, technology type The Gastrointestinal Symptoms Partnering 2010-2015 provides understanding and access to the gastrointestinal symptoms partnering deals ...  |  read more...
USD 1,495
The 2016-2021 World Outlook for Irritant Laxative Pharmaceutical Preparations
4/6/2015 | published by: Icon Group International, Inc.
... the latent demand, or potential industry earnings (P.I.E.), for the country in question (in millions of U.S. dollars), the percent share the country is of the region and of the globe. These comparative benchmarks allow ...  |  read more...
USD 995
Constipation Global Clinical Trials Review, H1, 2015
5/27/2015 | published by: GlobalData
... to the clinical trials on Constipation. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country ...  |  read more...
USD 2,500
The 2016 Report on Inflammatory Bowel Disease Therapeutics: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... advent of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so ...  |  read more...
USD 995
The 2016 Report on Peptic Ulcer Testing: World Market Segmentation by City
4/30/2015 | published by: Icon Group International, Inc.
... of a “borderless world”, cities become a more important criteria in prioritizing markets, as opposed to regions, continents, or countries. This report covers the top 2000 cities in over 200 countries. It does so by ...  |  read more...
USD 995
Spain Gastrointestinal (GI) Stenting Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... procedure volumes within market segments - GI Stenting Procedures using Fully Covered Gastrointestinal Stents, GI Stenting Procedures using Partially Covered Gastrointestinal Stents and GI Stenting Procedures using Non-Covered Gastrointestinal Stents. The data in the report ...  |  read more...
USD 1,000
United States Gastrointestinal (GI) Stenting Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... The report provides procedure volumes within market segments - GI Stenting Procedures using Fully Covered Gastrointestinal Stents, GI Stenting Procedures using Partially Covered Gastrointestinal Stents and GI Stenting Procedures using Non-Covered Gastrointestinal Stents. The data ...  |  read more...
USD 1,000
France Gastrointestinal (GI) Stenting Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... procedure volumes within market segments - GI Stenting Procedures using Fully Covered Gastrointestinal Stents, GI Stenting Procedures using Partially Covered Gastrointestinal Stents and GI Stenting Procedures using Non-Covered Gastrointestinal Stents. The data in the report ...  |  read more...
USD 1,000
Germany Gastrointestinal (GI) Stenting Procedures Outlook to 2020
7/1/2014 | published by: GlobalData
... procedure volumes within market segments - GI Stenting Procedures using Fully Covered Gastrointestinal Stents, GI Stenting Procedures using Partially Covered Gastrointestinal Stents and GI Stenting Procedures using Non-Covered Gastrointestinal Stents. The data in the report ...  |  read more...
USD 1,000
6  7  8  9    11    13  14  15